The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment or prevention of disorders and diseases mediated by agonists and antagonists of the progesterone receptor. The clinical uses of these compounds are related to contraception, the treatment and/or prevention of secondary amenorrhea, dysfunctional bleeding, uterine leiomyomata, endometriosis; polycystic ovary syndrome, carcinomas and adenocarcinomas of the endometrium, ovary, breast, colon, prostate, or minication of side effects of cyclid menstrual bleeding. Additional uses of the invention include stimulation of food intake.
RELATED APPLICATION
This application is a Divisional Application of Ser. No. 11/255,444, now U.S. Pat. No. 7,183,309, filed Oct. 21, 2005, which claims the benefit of U.S. Provisional Patent Application No. 60/622,582, filed Oct. 27, 2004, which is incorporated herein by reference in its entirety.
